EZH2 and neoplasm: The mechanism underlying this involves ANLN inhibition of miR-218-5p expression through regulation of the histone methyltransferase EZH2, thereby disinhibiting the downstream target gene LASP1 and promoting tumor cell proliferation (Wang et al., 2019).